<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Braga, Andrea</dc:creator>
  <dc:creator>Castronovo, Fabiana</dc:creator>
  <dc:creator>Caccia, Giorgio</dc:creator>
  <dc:creator>Papadia, Andrea</dc:creator>
  <dc:creator>Regusci, Luca</dc:creator>
  <dc:creator>Torella, Marco</dc:creator>
  <dc:creator>Salvatore, Stefano</dc:creator>
  <dc:creator>Scancarello, Chiara</dc:creator>
  <dc:creator>Ghezzi, Fabio</dc:creator>
  <dc:creator>Serati, Maurizio</dc:creator>
  <dc:date>2022</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Functional magnetic stimulation (FMS) is a new technique for the conservative treatment ofUrinary incontinence (UI), based on magnetic induction. It induces controlled depolarization of thenerves, resulting in pelvic muscle contraction and sacral S2-S4 roots neuromodulation. The aim of thisstudy was to assess the efficacy of the new 3 Tesla FMS chair, both in patients with pure stress urinaryincontinence (SUI) and in women with pure overactive bladder (OAB) symptoms.  A prospectiveobservational study was conducted in our urogynaecologic unit.  All the patients involved wereconsecutive women with pure SUI or pure OAB symptoms treated by a 3 Tesla electromagneticchair. The primary outcome was a subjective outcome evaluation by the PGI-I Scale and a patient-satisfaction scale.  The secondary outcome was the change score of the UDI-6, IIQ-7, ICIQ-SF andOAB-q SF questionnaires from baseline to final visit. At 2 months follow-up, 28 out of 60 patients(47%) with SUI symptoms and 20 out of 40 patients (50%) with OAB symptoms declared themselvescured. Considering cured and improved patients, the subjective cure rates were 68.3% (41/60) and70% (28/40) for patients with SUI and OAB symptoms, respectively. The results of this study showedthat the 3 Tesla electromagnetic chair may be an effective option for the treatment of UI.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/325639</dc:identifier>
  <dc:identifier>https://n2t.net/ark:/12658/srd1325639</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/325639/files/Braga_2022_MDPI_jcm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/jcm11102805</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1325639</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Journal of clinical medicine. - 2022, vol. 11, p. 2805</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Functional magnetic stimulation</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Extracorporeal magnetic innervation</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Chair</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Female urinary incontinence</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Stress urinary incontinence</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Overactive bladder</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns7="xml" ns7:lang="en">Efficacy of 3 Tesla functional magnetic stimulation for the treatment of female urinary incontinence</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>